GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹196 Cr | ₹146 Cr | ₹137 Cr | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹196 Cr |
| Mar2025 | ₹146 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 34.01 | |
| Mar2025 | ₹146 Cr | 6.40 | |
| Mar2024 | ₹137 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,657.0 Cr | 2.4% | 15.3% | 48.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.4% |
15.3% |
48.6% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses